Literature DB >> 9434819

Hepatoblastoma incidence in the United States from 1973 to 1992.

J A Ross1, J G Gurney.   

Abstract

BACKGROUND: There is recent evidence to suggest that extremely low birth weight is associated with the occurrence of hepatoblastoma. PROCEDURE: In light of this possibility, we evaluated trends in hepatoblastoma incidence in the United States among children age 4 years and younger.
RESULTS: We found an increasing trend (5.2%) in hepatoblastoma incidence over the past two decades, a period that corresponds with improved survival of very low birth weight children.
CONCLUSION: Future studies of hepatoblastoma that incorporate birth weight are appropriate.

Entities:  

Mesh:

Year:  1998        PMID: 9434819     DOI: 10.1002/(sici)1096-911x(199803)30:3<141::aid-mpo1>3.0.co;2-h

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  10 in total

1.  Treatment outcomes for hepatoblastoma: an institution's experience over two decades.

Authors:  J P Ang; J A Heath; S Donath; S Khurana; A Auldist
Journal:  Pediatr Surg Int       Date:  2006-11-21       Impact factor: 1.827

Review 2.  [Current status of diagnosis and treatment of hepatoblastoma].

Authors:  Purificación García-Miguel; Manuel López Santamaría
Journal:  Clin Transl Oncol       Date:  2005-08       Impact factor: 3.405

3.  What do we know about the etiology of hepatoblastoma?

Authors:  Lucie M Turcotte; Logan G Spector
Journal:  Hepat Oncol       Date:  2013-12-20

4.  The utility of alpha-fetoprotein screening in Beckwith-Wiedemann syndrome.

Authors:  Kelly A Duffy; Matthew A Deardorff; Jennifer M Kalish
Journal:  Am J Med Genet A       Date:  2017-02-04       Impact factor: 2.802

5.  Hepatic metastatic disease in pediatric and adolescent solid tumors.

Authors:  Israel Fernandez-Pineda; John A Sandoval; Andrew M Davidoff
Journal:  World J Hepatol       Date:  2015-07-18

6.  Maternal pregnancy events and exposures and risk of hepatoblastoma: a Children's Oncology Group (COG) study.

Authors:  Jessica R B Musselman; Michael K Georgieff; Julie A Ross; Gail E Tomlinson; James Feusner; Mark Krailo; Logan G Spector
Journal:  Cancer Epidemiol       Date:  2013-01-09       Impact factor: 2.984

7.  Cost-effectiveness Analysis of Screening Extremely Low Birth Weight Children for Hepatoblastoma Using Serum Alpha-fetoprotein.

Authors:  Rebecca MacDonell-Yilmaz; Kelly Anderson; Bradley DeNardo; Philippa Sprinz; William V Padula
Journal:  J Pediatr       Date:  2020-05-26       Impact factor: 4.406

8.  The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis.

Authors:  Sadafumi Azukisawa; Jianbo Zheng; Xin Guo; Hiroki Ura; Yo Niida; Tohru Itoh; Sohsuke Yamada
Journal:  Histol Histopathol       Date:  2021-09-03       Impact factor: 2.303

9.  Single-walled carbon nanohorn aggregates promotes mitochondrial dysfunction-induced apoptosis in hepatoblastoma cells by targeting SIRT3.

Authors:  Bowei Li; Xiaoxun Chen; Wenbin Yang; Jingliang He; Ke He; Zhenglin Xia; Jinqian Zhang; Guoan Xiang
Journal:  Int J Oncol       Date:  2018-06-28       Impact factor: 5.650

10.  Smoking and hepatoblastoma: confounding by birth weight?

Authors:  L G Spector; J A Ross
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.